bioavailability of oral semaglutide Safety and Pharmacokinetics Single and Multiple Ascending Doses of the Novel Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes | Clinical Pharmacokinetics Why Injectable Semaglutide Remains Superior:

Semaglutide (aka Ozempic or Wegovy) has become ubiquitous because of established benefits in diabetes and obesity but SELECT showed that the drug should be considered in those who are obese with established atherosclerotic CV disease (ASCVD.) In March of 2024 the FDA approved a new indication for Wegovy based on the SELECT trial to reduce the risk of CV death, stroke, and heart attack in adults with cardiovascular disease and either obese or overweight My Thoughts on Semaglutide for Secondary Prevention After looking in detail at SELECT I realized that it does not apply to most patients in my practice

doi: 10.1111/jdi.12625

Telehealth regulations vary by state, affecting your ability to access GLP-1 medications remotely

10.3390/ijms232012656 19 FangY